# CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

> **NCT05996393** · PHASE4 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 86 (actual)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Ciclosporin
- **DRUG:** Avatrombopag
- **DRUG:** Anti-Human Thymocyte Immunoglobulin, Rabbit

## Key facts

- **NCT ID:** NCT05996393
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-15
- **Primary completion:** 2025-02-20
- **Final completion:** 2025-02-27
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05996393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05996393, "CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05996393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*